NYSE:MOH
NYSE:MOHHealthcare

Reassessing Molina Healthcare (MOH) Valuation as Legal Probe Puts 2025 Guidance and Cost Assumptions in Focus

Grabar Law Office has launched an investigation into Molina Healthcare (MOH), questioning whether management adequately disclosed rising medical cost trends and a mismatch between premiums and underlying costs, which has put the company’s 2025 financial guidance under sharper investor scrutiny. See our latest analysis for Molina Healthcare. The investigation is landing after a volatile stretch, with Molina’s share price at $163.68 following a strong 1 month share price return, but a steep...
NasdaqGS:CTSH
NasdaqGS:CTSHIT

Cognizant’s Expanded Microsoft AI Alliance and New AI Labs Might Change The Case For Investing In Cognizant Technology Solutions (CTSH)

Cognizant recently announced a series of multi-year agreements, including an AI-focused partnership with Microsoft, new AI-driven BPaaS and IT modernization deals with Bupa Hong Kong, ERIKS, and BayWa, alongside the opening of an India AI Lab and Cognizant Moment Studio in Bengaluru to deepen applied AI research and innovation. Together, these moves highlight how Cognizant is integrating agentic AI and sector-specific platforms into core client workflows, aiming to reposition itself as an...
NYSE:VG
NYSE:VGOil and Gas

Venture Global (VG): Reassessing Valuation After a Sharp Short-Term Rebound and Steep Year-to-Date Decline

Venture Global (VG) has quietly turned into a roller coaster for investors, with the stock jumping 4% in a day but still sitting deeply red over the past 3 months and year to date. See our latest analysis for Venture Global. That sharp 1 day and 7 day share price return rebound comes after months of heavy selling, with the 90 day and year to date share price returns still pointing to fading momentum as investors reassess both growth prospects and risk. Given how quickly sentiment can swing in...
NasdaqGM:STAA
NasdaqGM:STAAMedical Equipment

Is STAAR Surgical A Bargain After Years of Share Price Declines?

Wondering if STAAR Surgical at around $24 a share is a hidden bargain or a value trap? You are not alone, and that is exactly what we are going to unpack. The stock has been choppy, up 2.7% over the last week but down 13.6% over the past month. Despite being barely positive year to date at 0.4%, it is still sitting on steep losses of around 50% over three years and 70% over five. Those big swings are set against a backdrop of ongoing excitement around implantable Collamer lenses and the...
NasdaqGS:LAES
NasdaqGS:LAESSemiconductor

Is SEALSQ (LAES) Quietly Repositioning as a Post‑Quantum Cybersecurity Platform Play?

SEALSQ’s recently announced partnership with Airmod delivered a production-ready, open-source-enabled middleware stack built on SEALSQ Secure DevKits to speed deployment of quantum-resistant IoT devices, alongside appointing industry veteran Rolf Gobet to lead its Geneva Quantum Center of Excellence within the Europe-focused Quantum Corridor initiative. Together, the Airmod collaboration and Gobet’s leadership role highlight SEALSQ’s push to offer end-to-end post-quantum cybersecurity...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Is There Still Value in Amgen After Its Strong 2025 Share Price Run?

Wondering if Amgen’s share price already reflects the upside, or if there is still value on the table? You are not alone, and this article is going to tackle that head on from an investor’s perspective. Amgen’s stock has quietly put in a solid run, with the price up 1.9% over the last week and 27.8% year to date, even after a small 1.8% pullback over the last month that reminds us risk perceptions can change quickly. Recent attention has centered on Amgen’s expanding pipeline in areas like...
NYSE:ITW
NYSE:ITWMachinery

Illinois Tool Works (ITW): Is the Quiet Grind Higher Backed by Its Current Valuation?

Illinois Tool Works (ITW) has been quietly grinding higher this month, and that slow climb is catching investors attention. With steady earnings growth and a long dividend track record, the stock invites a closer look. See our latest analysis for Illinois Tool Works. At around $251.57 per share, Illinois Tool Works is treading water in the short term, with a modestly positive year to date share price return but a much stronger three year total shareholder return suggesting the longer term...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

The Bull Case For Walmart (WMT) Could Change Following FDA Formula Warning And ESOP Shift - Learn Why

In recent weeks, Walmart has expanded and refreshed key product lines through partners like No Cap! Soda Pop, AXIL Brands, and Dove x Crumbl, while also facing an FDA warning letter over recalled ByHeart infant formula remaining on its shelves after a nationwide recall. At the same time, Walmart has closed older employee stock ownership plan shelf registrations, filed a new multi-billion-dollar ESOP-related registration, and joined the Nasdaq Composite Index, underscoring how employee...